Open AccessClopidogrel Versus Ticagrelor or Prasugrel After Primary Percutaneous Coronary Intervention According to CYP2C19 Genotype
Author(s) -
Daniel M.F. Claassens,
Thomas O. Bergmeijer,
Gerrit J.A. Vos,
Renicus S. Hermanides,
Arnoud W.J. van ‘t Hof,
Pim van der Harst,
Emanuele Barbato,
Carmine Morisco,
Richard M. Tjon Joe Gin,
Folkert W. Asselbergs,
Arend Mosterd,
JeanPaul R. Herrman,
Willem J.M. Dewilde,
Paul W.A. Janssen,
Johannes C. Kelder,
Bakhtawar K. Mahmoodi,
Vera H.M. Deneer,
Jurriën M. ten Berg
Publication year - 2021
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.120.009434
Subject(s) - prasugrel , ticagrelor , clopidogrel , medicine , cyp2c19 , cardiology , percutaneous coronary intervention , myocardial infarction , cytochrome p450 , metabolism
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom